{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T01:05:28Z","timestamp":1792285528420,"version":"4.4.0"},"reference-count":54,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2015,11,13]],"date-time":"2015-11-13T00:00:00Z","timestamp":1447372800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2015,11,13]],"date-time":"2015-11-13T00:00:00Z","timestamp":1447372800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Hepatology"],"published-print":{"date-parts":[[2016,1]]},"abstract":"<jats:p>Perinatal or mother\u2010to\u2010child transmission (MTCT) of hepatitis B virus (HBV) remains the major risk factor for chronic HBV infection worldwide. In addition to hepatitis B immune globulin and vaccination, oral antiviral therapies in highly viremic mothers can further decrease MTCT of HBV. We conducted a systematic review and meta\u2010analysis to synthesize the evidence on the efficacy and maternal and fetal safety of antiviral therapy during pregnancy. A protocol was developed by the American Association for the Study of Liver Diseases guideline writing committee. We searched multiple databases for controlled studies that enrolled pregnant women with chronic HBV infection treated with antiviral therapy. Outcomes of interest were reduction of MTCT and adverse outcomes to mothers and newborns. Study selection and data extraction were done by pairs of independent reviewers. We included 26 studies that enrolled 3622 pregnant women. Antiviral therapy reduced MTCT, as defined by infant hepatitis B surface antigen seropositivity (risk ratio = 0.3, 95% confidence interval 0.2\u20100.4) or infant HBV DNA seropositivity (risk ratio = 0.3, 95% confidence interval 0.2\u20100.5) at 6\u201012 months. No significant differences were found in the congenital malformation rate, prematurity rate, and Apgar scores. Compared to control, lamivudine or telbivudine improved maternal HBV DNA suppression at delivery and during 4\u20108 weeks' postpartum follow\u2010up. Tenofovir showed improvement in HBV DNA suppression at delivery. No significant differences were found in postpartum hemorrhage, cesarean section, and elevated creatinine kinase rates. <jats:italic toggle=\"yes\">Conclusions:<\/jats:italic> Antiviral therapy improves HBV suppression and reduces MTCT in women with chronic HBV infection with high viral load compared to the use of hepatitis B immunoglobulin and vaccination alone; the use of telbivudine, lamivudine, and tenofovir appears to be safe in pregnancy with no increased adverse maternal or fetal outcome. (H<jats:sc>epatology<\/jats:sc> 2016;63:319\u2013333)<\/jats:p>","DOI":"10.1002\/hep.28302","type":"journal-article","created":{"date-parts":[[2015,11,13]],"date-time":"2015-11-13T20:46:31Z","timestamp":1447447591000},"page":"319-333","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":282,"title":["Antiviral therapy in chronic hepatitis B viral infection during pregnancy: A systematic review and meta\u2010analysis"],"prefix":"10.1097","volume":"63","author":[{"given":"Robert S.","family":"Brown","sequence":"first","affiliation":[{"name":"Division of Gastroenterology and Hepatology,Weill Cornell Medical College,New York,NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian J.","family":"McMahon","sequence":"additional","affiliation":[{"name":"Liver Diseases and Hepatitis Program,Alaska Native Tribal Health Consortium,Anchorage,AK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna S.F.","family":"Lok","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology,University of Michigan,Ann Arbor,MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John B.","family":"Wong","sequence":"additional","affiliation":[{"name":"Division of Clinical Decision Making,Tufts Medical Center,Boston,MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed T.","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Evidence\u2010Based Practice Research Program"},{"name":"Center for the Science of Health Care Delivery"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.","family":"Mouchli","sequence":"additional","affiliation":[{"name":"Division of Hospital Internal Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Wang","sequence":"additional","affiliation":[{"name":"Evidence\u2010Based Practice Research Program"},{"name":"Center for the Science of Health Care Delivery"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry J.","family":"Prokop","sequence":"additional","affiliation":[{"name":"Library Public Services"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Hassan","family":"Murad","sequence":"additional","affiliation":[{"name":"Evidence\u2010Based Practice Research Program"},{"name":"Center for the Science of Health Care Delivery"},{"name":"Division of Preventive, Occupational and Aerospace Medicine,Mayo Clinic,Rochester,MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled","family":"Mohammed","sequence":"additional","affiliation":[{"name":"Evidence\u2010Based Practice Research Program"},{"name":"Center for the Science of Health Care Delivery"},{"name":"Division of Preventive, Occupational and Aerospace Medicine,Mayo Clinic,Rochester,MN"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2015,11,13]]},"reference":[{"issue":"Suppl","key":"hep28302-bib-0001-20241017","first-page":"S18","article-title":"Hepatitis B: global importance and need for control","volume":"8","year":"1990","journal-title":"Vaccine"},{"key":"hep28302-bib-0002-20241017","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1093\/infdis\/146.2.198","article-title":"Incidence of hepatitis B virus infections in preschool children in Taiwan","volume":"146","year":"1982","journal-title":"J Infect Dis"},{"key":"hep28302-bib-0003-20241017","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1001\/jama.1990.03440090052025","article-title":"The changing epidemiology of hepatitis B in the United States. Need for alternative vaccination strategies","volume":"263","year":"1990","journal-title":"JAMA"},{"key":"hep28302-bib-0004-20241017","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1056\/NEJM197504102921503","article-title":"Vertical transmission of hepatitis B antigen in Taiwan","volume":"292","year":"1975","journal-title":"N Engl J Med"},{"key":"hep28302-bib-0005-20241017","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1016\/0016-5085(87)90613-5","article-title":"Spontaneous hepatitis B e antigen to antibody seroconversion and reversion in Chinese patients with chronic hepatitis B virus infection","volume":"92","year":"1987","journal-title":"Gastroenterology"},{"key":"hep28302-bib-0006-20241017","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1002\/hep.1840080527","article-title":"A longitudinal follow\u2010up of asymptomatic hepatitis B surface antigen\u2010positive Chinese children","volume":"8","year":"1988","journal-title":"Hepatology"},{"key":"hep28302-bib-0007-20241017","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/jmv.1890130410","article-title":"Age\u2010specific prevalence and significance of hepatitis B e antigen and antibody in chronic hepatitis B virus infection in Taiwan: a comparison among asymptomatic carriers, chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma","volume":"13","year":"1984","journal-title":"J Med Virol"},{"key":"hep28302-bib-0008-20241017","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1001\/jama.1985.03350360066020","article-title":"Perinatal hepatitis B virus transmission in the United States. Prevention by passive\u2010active immunization","volume":"253","year":"1985","journal-title":"JAMA"},{"key":"hep28302-bib-0009-20241017","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1053\/j.gastro.2007.08.010","article-title":"Clearance of hepatitis B e antigen in patients with chronic hepatitis B and genotypes A, B, C, D, and F","volume":"133","year":"2007","journal-title":"Gastroenterology"},{"key":"hep28302-bib-0010-20241017","doi-asserted-by":"crossref","first-page":"489","DOI":"10.5694\/j.1326-5377.2009.tb02524.x","article-title":"Perinatal transmission of hepatitis B virus: an Australian experience","volume":"190","year":"2009","journal-title":"Med J Aust"},{"key":"hep28302-bib-0011-20241017","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1093\/infdis\/170.6.1418","article-title":"Outcome of perinatal hepatitis B virus exposure is dependent on maternal virus load","volume":"170","year":"1994","journal-title":"J Infect Dis"},{"key":"hep28302-bib-0012-20241017","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.3748\/wjg.v10.i21.3215","article-title":"Effect of hepatitis B immunoglobulin on interruption of HBV intrauterine infection","volume":"10","year":"2004","journal-title":"World J Gastroenterol"},{"key":"hep28302-bib-0013-20241017","first-page":"e18","article-title":"Virologic factors associated with failure to passive\u2010active immunoprophylaxis in infants born to HBsAg\u2010positive mothers","volume":"19","year":"2012","journal-title":"J Viral Hepat"},{"key":"hep28302-bib-0014-20241017","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hep.23190","article-title":"Chronic hepatitis B: update 2009","volume":"50","year":"2009","journal-title":"Hepatology"},{"key":"hep28302-bib-0015-20241017","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1002\/hep.22841","article-title":"Long\u2010term monitoring shows hepatitis B virus resistance to entecavir in nucleoside\u2010naive patients is rare through 5 years of therapy","volume":"49","year":"2009","journal-title":"Hepatology"},{"key":"hep28302-bib-0016-20241017","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1053\/j.gastro.2006.09.020","article-title":"Long\u2010term therapy with adefovir dipivoxil for HBeAg\u2010negative chronic hepatitis B for up to 5 years","volume":"131","year":"2006","journal-title":"Gastroenterology"},{"key":"hep28302-bib-0017-20241017","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/hep.23785","article-title":"Long\u2010term entecavir therapy results in the reversal of fibrosis\/cirrhosis and continued histological improvement in patients with chronic hepatitis B","volume":"52","year":"2010","journal-title":"Hepatology"},{"key":"hep28302-bib-0018-20241017","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cgh.2010.11.040","article-title":"Long\u2010term treatment with entecavir induces reversal of advanced fibrosis or cirrhosis in patients with chronic hepatitis B","volume":"9","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"hep28302-bib-0019-20241017","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/AOG.0b013e3181e45951","article-title":"Lamivudine in late pregnancy to interrupt in utero transmission of hepatitis B virus: a systematic review and meta\u2010analysis","volume":"116","year":"2010","journal-title":"Obstet Gynecol"},{"key":"hep28302-bib-0020-20241017","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.jhep.2012.06.031","article-title":"Hepatitis B virus and human immunodeficiency virus drugs in pregnancy: findings from the Antiretroviral Pregnancy Registry","volume":"57","year":"2012","journal-title":"J Hepatol"},{"key":"hep28302-bib-0021-20241017","first-page":"e123","article-title":"Preferred reporting items for systematic reviews and meta\u2010analyses: the PRISMA Statement","volume":"3","year":"2009","journal-title":"Open Med"},{"key":"hep28302-bib-0022-20241017","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1001\/jama.2014.5559","article-title":"How to read a systematic review and meta\u2010analysis and apply the results to patient care: users' guides to the medical literature","volume":"312","year":"2014","journal-title":"JAMA"},{"key":"hep28302-bib-0023-20241017","doi-asserted-by":"crossref","first-page":"d4002","DOI":"10.1136\/bmj.d4002","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta\u2010analyses of randomised controlled trials","volume":"343","year":"2011","journal-title":"BMJ"},{"key":"hep28302-bib-0024-20241017","doi-asserted-by":"crossref","first-page":"4321","DOI":"10.3748\/wjg.v17.i38.4321","article-title":"A meta\u2010analysis of lamivudine for interruption of mother\u2010to\u2010child transmission of hepatitis B virus","volume":"17","year":"2011","journal-title":"World JGastroenterol"},{"key":"hep28302-bib-0025-20241017","first-page":"571","article-title":"Telbivudine during the second and third trimester of pregnancy interrupts HBV intrauterine transmission: a systematic review and meta\u2010analysis","volume":"60","year":"2014","journal-title":"Clin Lab"},{"key":"hep28302-bib-0026-20241017","first-page":"561","article-title":"Blocking intrauterine infection by telbivudine in pregnant chronic hepatitis B patients","volume":"17","year":"2009","journal-title":"Chung Hua Kan Tsang Ping Tsa Chih"},{"key":"hep28302-bib-0027-20241017","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1365-2893.2008.01056.x","article-title":"Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double\u2010blind, placebo\u2010controlled study","volume":"16","year":"2009","journal-title":"J Viral Hepat"},{"key":"hep28302-bib-0028-20241017","first-page":"329","article-title":"Effect of high viral hepatitis B virus DNA loads on vertical transmission of hepatitis B virus in late\u2010pregnant women","volume":"43","year":"2008","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"key":"hep28302-bib-0029-20241017","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.3748\/wjg.v9.i7.1501","article-title":"Interruption of HBV intrauterine transmission: a clinical study","volume":"9","year":"2003","journal-title":"World J Gastroenterol"},{"key":"hep28302-bib-0030-20241017","first-page":"367","article-title":"The clinical observation of effect of lamivudine on interrupting mother to infant transmission of chronic HBV on 50 mothers","volume":"26","year":"2010","journal-title":"J Pract Obstet Gynecol"},{"key":"hep28302-bib-0032-20241017","first-page":"1730","article-title":"Effect of lamivudine treatment combined with active\u2010passive immunization on interrupting mother to infant transmission of HBV","volume":"23","year":"2008","journal-title":"Clin Focus"},{"key":"hep28302-bib-0033-20241017","first-page":"14","article-title":"Evaluation of therapeutic effect in HBV vertical transmission by lamivudine treatment combined with active\u2010passive immunization for pregnant women","volume":"2","year":"2007","journal-title":"Chin Prac Med"},{"key":"hep28302-bib-0034-20241017","first-page":"77","article-title":"Study of lamivudine in interruption of HBV intrauterine infection","volume":"21","year":"2005","journal-title":"Clin Med Chin"},{"key":"hep28302-bib-0035-20241017","first-page":"368","article-title":"Observation the role of telbivudine in blocking mother\u2010to\u2010child transmission of HBV in pregnant women with high viral load","volume":"25","year":"2011","journal-title":"Journal of Changzhl Medical College"},{"key":"hep28302-bib-0036-20241017","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/hep.27034","article-title":"Telbivudine or lamivudine use in late pregnancy safely reduces perinatal transmission of hepatitis B virus in real\u2010life practice","volume":"60","year":"2014","journal-title":"Hepatology"},{"key":"hep28302-bib-0037-20241017","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jhep.2014.04.038","article-title":"Efficacy and safety of tenofovir disoproxil fumarate in pregnancy to prevent perinatal transmission of hepatitis B virus","volume":"61","year":"2014","journal-title":"J Hepatol"},{"key":"hep28302-bib-0038-20241017","doi-asserted-by":"crossref","first-page":"9377","DOI":"10.3748\/wjg.v19.i48.9377","article-title":"Efficacy and safety of tenofovir disoproxil fumarate in pregnancy for the prevention of vertical transmission of HBV infection","volume":"19","year":"2013","journal-title":"World J Gastroenterol"},{"key":"hep28302-bib-0039-20241017","first-page":"888","article-title":"Maternal\u2010fetal outcomes of lamivudine treatment administered during late pregnancy to highly viremic mothers with HBeAg+ chronic hepatitis B","volume":"20","year":"2012","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"key":"hep28302-bib-0040-20241017","first-page":"703","article-title":"Efficacy of telbivudine in blocking the vertical transmission and the safety observation of discontinuing treatment time after delivery on mother infected with HBV","volume":"20","year":"2012","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"key":"hep28302-bib-0041-20241017","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1007\/s10096-012-1557-2","article-title":"The efficacy and safety of antiviral therapy with lamivudine to stop the vertical transmission of hepatitis B virus","volume":"31","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"hep28302-bib-0042-20241017","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.cgh.2012.01.019","article-title":"Telbivudine prevents vertical transmission from HBeAg\u2010positive women with chronic hepatitis B","volume":"10","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"hep28302-bib-0043-20241017","first-page":"201","article-title":"Efficacy and safety of telbivudine in pregnant women to prevent perinatal transmission of hepatitis B virus","volume":"20","year":"2012","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"key":"hep28302-bib-0044-20241017","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.jhep.2011.02.032","article-title":"A prospective and open\u2010label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection","volume":"55","year":"2011","journal-title":"J Hepatol"},{"key":"hep28302-bib-0045-20241017","first-page":"1019","article-title":"Effect on interruption of hepatitis B virus vertical transmission by lamivudine","volume":"22","year":"2007","journal-title":"J Appl Clin Pediatr"},{"key":"hep28302-bib-0046-20241017","first-page":"106","article-title":"Clinical effect and safety of lamivudine in interruption of chronic HBV maternal to infant transmission","volume":"11","year":"2006","journal-title":"Chin Hepatol"},{"key":"hep28302-bib-0047-20241017","first-page":"378","article-title":"Effect and safety of preventing HBV vertical transmission by lamivudine treatment","volume":"44","year":"2005","journal-title":"Chin J Intern Med"},{"key":"hep28302-bib-0048-20241017","first-page":"259","article-title":"The efficacy and safety of telbivudine in blocking intrauterine hepatitis B viral transmission","volume":"14","year":"2011","journal-title":"J Clin Hepatol"},{"key":"hep28302-bib-0049-20241017","first-page":"157","article-title":"Efficacy and safety of telbivudin in preventing mother\u2010to\u2010infant HBV tranmission","volume":"12","year":"2010","journal-title":"Adverse Drug Reactions"},{"key":"hep28302-bib-0050-20241017","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/hep.27837","article-title":"Efficacy of maternal tenofovir disoproxil fumarate in interrupting mother\u2010to\u2010infant transmission of hepatitis B virus","volume":"62","year":"2015","journal-title":"Hepatology"},{"key":"hep28302-bib-0051-20241017","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jcv.2014.06.005","article-title":"Comparison of telbivudine versus lamivudine in interrupting perinatal transmission of hepatitis B virus","volume":"61","year":"2014","journal-title":"J Clin Virol"},{"key":"hep28302-bib-0052-20241017","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1093\/cid\/civ437","article-title":"Lower newborn bone mineral content associated with maternal use of tenofovir disoproxil fumarate during pregnancy","volume":"61","year":"2015","journal-title":"Clin Infect Dis"},{"key":"hep28302-bib-0053-20241017","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1097\/QAD.0b013e328352d135","article-title":"Safety of tenofovir use during pregnancy: early growth outcomes in HIV\u2010exposed uninfected infants","volume":"26","year":"2012","journal-title":"AIDS"},{"key":"hep28302-bib-0054-20241017","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1053\/j.gastro.2003.09.033","article-title":"Long\u2010term safety of lamivudine treatment in patients with chronic hepatitis B","volume":"125","year":"2003","journal-title":"Gastroenterology"},{"key":"hep28302-bib-0055-20241017","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1053\/j.gastro.2010.10.011","article-title":"Three\u2010year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B","volume":"140","year":"2011","journal-title":"Gastroenterology"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.28302","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.28302","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-201601000-00035","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T00:17:42Z","timestamp":1729210662000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-201601000-00035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,13]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.28302","relation":{},"ISSN":["0270-9139","1527-3350"],"issn-type":[{"value":"0270-9139","type":"print"},{"value":"1527-3350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,13]]},"assertion":[{"value":"2015-08-18","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-10-15","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}